Analyzing a consecutive series of MCC from three centers in Turin, the aim of our study was twofold: i) to investigate the prognostic/predictive role of MCPyV status, ALK tumor expression and clinical-pathological parameters in respect to patient’s progression and outcome, and ii) to analyze and confirm the apparent increase in MCC incidence in the last decades. This evidence concerns the gene ALK and Merkel cell skin cancer.